Extended-Duration Venous Thromboembolism Prophylaxis for Medical Patients
Authors: Jose A. Nieto, Reina Valle, Juan B. Lopez-Saez
Journal: Annals of Internal Medicine (2010)

Letters16 November 2010Extended-Duration Venous Thromboembolism Prophylaxis for Medical PatientsJose A. Nieto, PhD, Reina Valle, PhD, and Juan B. Lopez-Saez, PhDJose A. Nieto, PhDFrom Hospital General Virgen De La Luz, 16002 Cuenca, Spain; Hospital Sierrallana, 39300 Torrelavega, Spain; and Hospital Universitario Puerto Real, 11510 Puerto Real, Spain.Search for more papers by this author, Reina Valle, PhDFrom Hospital General Virgen De La Luz, 16002 Cuenca, Spain; Hospital Sierrallana, 39300 Torrelavega, Spain; and Hospital Universitario Puerto Real, 11510 Puerto Real, Spain.Search for more papers by this author, and Juan B. Lopez-Saez, PhDFrom Hospital General Virgen De La Luz, 16002 Cuenca, Spain; Hospital Sierrallana, 39300 Torrelavega, Spain; and Hospital Universitario Puerto Real, 11510 Puerto Real, Spain.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-10-201011160-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In the excellent EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study, Hull and coworkers (1) reported on the benefits of a fixed dose of 40 mg of enoxaparin on the extended duration of thromboembolism prophylaxis for patients with level 1 immobility, women, and patients older than 75 years. We hypothesize that the better outcomes observed in the last 2 groups are dependent on the weight-adjusted dosage of enoxaparin administered.According to RIETE (Registro Informatizado de Enfermedad Tromboembólica) registry data, women (older than 40 years) with venous thromboembolism (VTE) weighed significantly ...Reference1. Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Nicol P, et al; EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med. 2010;153:8-18. [PMID: 20621900] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Hospital General Virgen De La Luz, 16002 Cuenca, Spain; Hospital Sierrallana, 39300 Torrelavega, Spain; and Hospital Universitario Puerto Real, 11510 Puerto Real, Spain.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoExtended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility Russell D. Hull , Sebastian M. Schellong , Victor F. Tapson , Manuel Monreal , Meyer-Michel Samama , Philippe Nicol , Eric Vicaut , Alexander G.G. Turpie , Roger D. Yusen , and Extended-Duration Venous Thromboembolism Prophylaxis for Medical Patients Michael P. Carson and Yen-Hong Kuo Extended-Duration Venous Thromboembolism Prophylaxis for Medical Patients Russell D. Hull and Extended-Duration Venous Thromboembolism Prophylaxis for Medical Patients Francesco Dentali , Monica Gianni , and Alessandro Squizzato Metrics 16 November 2010Volume 153, Issue 10Page: 688-689KeywordsBody weightConflicts of interestProphylaxisVenous thromboembolism ePublished: 16 November 2010 Issue Published: 16 November 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...